24.1 C
New Delhi
Tuesday, October 12, 2021
HomeIndiaGurugram's Fortis Memorial Research Institute begins Sputnik vaccine trial run for public

Gurugram’s Fortis Memorial Research Institute begins Sputnik vaccine trial run for public


Image source: AP

Memorial Research Institute Gurugram Fortis Begins Trial Launch of Sputnik V to the Public

Gurugram’s Fortis Memorial Research Institute has begun a trial run of the Russian COVID-19 vaccine Sputnik V to the general public. Various private hospitals in Delhi-NCR have not yet been able to begin vaccine administration.

“We are in the process of rolling out the Sputnik V vaccine against Covid-19. We are not clear on the deployment dates for the vaccine and we will announce it by the evening, ”said a spokesman for Indraprastha Apollo Hospital.

The center has set the price for the Russian vaccine at Rs 1,145 per dose. The maximum price for Covishield for private COVID-19 vaccination centers (CVCs) was set at Rs 780 per dose, and for Covaxin at Rs 1,410 per dose.

Meanwhile, Madhukar Rainbow Children’s Hospital in Malwiya Nagar also said the hospital has yet to receive supplies of Sputnik V from Dr. Reddy’s laboratories in Hyderabad. “Suppliers are being delayed. We expect him soon, ”said a hospital spokesman.

The Gamaleya Russian National Research Institute of Epidemiology and Microbiology has developed a vaccine, and the Russian Direct Investment Fund (RDIF) sells it worldwide.

Dr Reddy’s Laboratories imports injections from Russia. After a while, the vaccine will also be produced in India. According to Gamaleya and RDIF, Sputnik V demonstrated 92% efficiency.

READ MORE: Satellite V is not yet available in many hospitals in Delhi – NCR

Latest India News



RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments